TELO
NASDAQ · Pharmaceuticals
Telomir Pharmaceuticals Inc
$0.78
-0.09 (-10.85%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price in Context
52-Week High
$1.58
-50.6% from high
52-Week Low
$0.78
+0.0% from low
Next Earnings Report
Nov 9, 2026
1d
tomorrow
EPS Est: $-0.08
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals